Influence of magnetic field strength on magnetic resonance imaging radiomics features in brain imaging, an in vitro and in vivo study

Archive ouverte

Ammari, Samy | Pitre-Champagnat, Stéphanie | Dercle, Laurent | Chouzenoux, Emilie | Moalla, Salma | Reuze, Sylvain | Talbot, Hugues | Mokoyoko, Tite | Hadchiti, Joya | Diffetocq, Sebastien | Volk, Andreas | El Haik, Mickeal | Lakiss, Sara | Balleyguier, Corinne | Lassau, Nathalie | Bidault, Francois

Edité par CCSD ; Frontiers Media -

International audience. Background: The development and clinical adoption of quantitative imaging biomarkers (radiomics) has established the need for the identification of parameters altering radiomics reproducibility. The aim of this study was to assess the impact of magnetic field strength on magnetic resonance imaging (MRI) radiomics features in neuroradiology clinical practice.Methods: T1 3D SPGR sequence was acquired on two phantoms and 10 healthy volunteers with two clinical MR devices from the same manufacturer using two different magnetic fields (1.5 and 3T). Phantoms varied in terms of gadolinium concentrations and textural heterogeneity. 27 regions of interest were segmented (phantom: 21, volunteers: 6) using the LIFEX software. 34 features were analyzed.Results: In the phantom dataset, 10 (67%) out of 15 radiomics features were significantly different when measured at 1.5T or 3T (student’s t-test, p < 0.05). Gray levels resampling, and pixel size also influence part of texture features. These findings were validated in healthy volunteers.Conclusions: According to daily used protocols for clinical examinations, radiomic features extracted on 1.5T should not be used interchangeably with 3T when evaluating texture features. Such confounding factor should be adjusted when adapting the results of a study to a different platform, or when designing a multicentric trial.

Suggestions

Du même auteur

Machine-Learning-Based Radiomics MRI Model for Survival Prediction of Recurrent Glioblastomas Treated with Bevacizumab

Archive ouverte | Ammari, Samy | CCSD

International audience. Anti-angiogenic therapy with bevacizumab is a widely used therapeutic option for recurrent glioblastoma (GBM). Nevertheless, the therapeutic response remains highly heterogeneous among GBM pa...

Liquid Biopsy versus CT: Comparison of Tumor Burden Quantification in 1065 Patients with Metastases

Archive ouverte | Dawi, Lama | CCSD

International audience. Tumor fraction at liquid biopsy was weakly correlated with the total tumor volume at contrast-enhanced CT and did not accurately reflect the tumor burden at contrast-enhanced CT.

Imaging-guided prognostic score-based approach to assess the benefits of combotherapy versus monotherapy with immune checkpoint inhibitors in metastatic MSI-H colorectal cancer patients

Archive ouverte | Barbe, Rémy | CCSD

International audience. BackgroundThis retrospective study determined survival responses to immune checkpoint inhibitors (ICIs), comparing mono- (mono) and combo-immunotherapy (combo) in patients with microsatellite...

Chargement des enrichissements...